| (+)-Rocaglamide |
|
|
|
|
|
|
|
|
| (5E,9E,13E)-Teprenone |
|
|
|
|
|
|
|
99.88% |
| (±)-Iroxanadine |
|
|
|
|
|
|
|
|
| 1,6-Dimethoxyhexane |
|
|
|
|
|
|
|
|
| 10,11-Dehydrocurvularin |
|
|
|
|
|
|
|
99.59% |
| 116-9e |
|
|
|
|
|
|
|
98.28% |
| 17-AEP-GA |
|
|
|
|
|
|
|
|
| 17-Demethoxy-reblastatin |
|
|
|
|
|
|
|
|
| 17-DMAP-GA |
|
|
|
|
|
|
|
|
| 17-GMB-APA-GA |
|
|
|
|
|
|
|
|
| 19-epi-Scholaricine |
|
|
|
|
|
|
|
99.14% |
| 2-Chloro-ADP |
|
|
|
|
|
|
|
|
| 2-Chloro-ADP sodium |
|
|
|
|
|
|
|
|
| 2-Hexyl-4-pentynoic acid |
|
|
|
|
|
|
|
98.0% |
| 2-Methoxyhydroquinone |
|
|
|
|
|
|
|
99.57% |
| 3-Phenyltoxoflavin |
|
|
|
|
|
|
|
99.83% |
| 4-Br-Bnlm |
|
|
|
|
|
|
|
99.46% |
| Mequinol |
|
|
|
|
|
|
|
99.81% |
| 6BrCaQ |
|
|
|
|
|
|
|
|
| 6BrCaQ-C10-TPP |
|
|
|
|
|
|
|
|
| [Au(TPP)]Cl |
|
|
|
|
|
|
|
|
| A17 peptide |
|
|
|
|
|
|
|
|
| A8 peptide |
|
|
|
|
|
|
|
|
| AChE/BChE-IN-37 |
|
|
|
|
|
|
|
|
| Adezmapimod |
|
|
|
|
|
|
|
99.93% |
| Aha1/Hsp90-IN-2 |
|
|
|
|
|
|
|
|
| AlF-NOTA-c-d-VAP |
|
|
|
|
|
|
|
|
| Aminohexylgeldanamycin |
|
|
|
|
|
|
|
99.82% |
| Aminohexylgeldanamycin hydrochloride |
|
|
|
|
|
|
|
|
| AMP-PCP |
|
|
|
|
|
|
|
|
| AMP-PCP disodium |
|
|
|
|
|
|
|
99.91% |
| Androgen receptor degrader-6 |
|
|
|
|
|
|
|
|
| Anti-Human/Mouse GRP78 Antibody (C38) |
|
|
|
|
|
|
|
95.00% |
| Anti-Human/Mouse GRP78 Antibody (N88) |
|
|
|
|
|
|
|
|
| Anticancer agent 249 |
|
|
|
|
|
|
|
|
| Antiproliferative agent-72 |
|
|
|
|
|
|
|
|
| Antitumor agent-174 |
|
|
|
|
|
|
|
|
| Antitumor agent-47 |
|
|
|
|
|
|
|
|
| AP-4-139B |
|
|
|
|
|
|
|
98.87% |
| Apatorsen |
|
|
|
|
|
|
|
98.54% |
| Apatorsen sodium |
|
|
|
|
|
|
|
98.54% |
| Apatorsen sodium scrambled negative control |
|
|
|
|
|
|
|
|
| Apoptozole |
|
|
|
|
|
|
|
99.71% |
| AR/AR-V7 degrader-1 |
|
|
|
|
|
|
|
|
| Araloside C |
|
|
|
|
|
|
|
99.78% |
| Arimoclomol |
|
|
|
|
|
|
|
99.83% |
| Arimoclomol citrate |
|
|
|
|
|
|
|
99.76% |
| Arimoclomol maleate |
|
|
|
|
|
|
|
99.95% |
| AT-533 |
|
|
|
|
|
|
|
98.38% |
| Autophagy activator-1 |
|
|
|
|
|
|
|
|
| BAG3/HSP70-IN-1 |
|
|
|
|
|
|
|
|
| BF844 |
|
|
|
|
|
|
|
|
| BIIB-028 |
|
|
|
|
|
|
|
|
| BIIB021 |
|
|
|
|
|
|
|
99.19% |
| BIIB021 mesylate |
|
|
|
|
|
|
|
|
| BiP substrate |
|
|
|
|
|
|
|
99.82% |
| BMS-358233 |
|
|
|
|
|
|
|
|
| BOLD-100 free base |
|
|
|
|
|
|
|
|
| BX-2819 |
|
|
|
|
|
|
|
|
| C086 |
|
|
|
|
|
|
|
|
| Caesappanin C |
|
|
|
|
|
|
|
98.09% |
| Casuarinin |
|
|
|
|
|
|
|
98.24% |
| CC-11 |
|
|
|
|
|
|
|
|
| CCT018159 |
|
|
|
|
|
|
|
99.30% |
| CCT245232 |
|
|
|
|
|
|
|
99.37% |
| CCT251236 |
|
|
|
|
|
|
|
99.04% |
| CDC20/HSP90-IN-1 |
|
|
|
|
|
|
|
|
| Cemdomespib |
|
|
|
|
|
|
|
|
| CH5015765 |
|
|
|
|
|
|
|
98.01% |
| CH5138303 |
|
|
|
|
|
|
|
99.04% |
| CH5164840 |
|
|
|
|
|
|
|
|
| Chaperone complex ligand 1 |
|
|
|
|
|
|
|
|
| Chetomin |
|
|
|
|
|
|
|
95.3% |
| Cholesterol β-D-glucoside |
|
|
|
|
|
|
|
99.38% |
| CliMB-325 |
|
|
|
|
|
|
|
|
| Col003 |
|
|
|
|
|
|
|
99.46% |
| Conglobatin |
|
|
|
|
|
|
|
95.48% |
| CPUY201112 |
|
|
|
|
|
|
|
|
| CT-1 |
|
|
|
|
|
|
|
99.90% |
| CYD0682 |
|
|
|
|
|
|
|
|
| CYP51/Hsp90-IN-1 |
|
|
|
|
|
|
|
|
| DCB-3503 |
|
|
|
|
|
|
|
|
| DCEM1 |
|
|
|
|
|
|
|
99.31% |
| DDO-5936 |
|
|
|
|
|
|
|
98.33% |
| DDO-6600 |
|
|
|
|
|
|
|
98.19% |
| DDO-6691 |
|
|
|
|
|
|
|
|
| DDO3602 |
|
|
|
|
|
|
|
|
| Debio 0932 |
|
|
|
|
|
|
|
99.76% |
| Dehydroherbarin |
|
|
|
|
|
|
|
|
| Delphinidin-3-O-galactoside chloride |
|
|
|
|
|
|
|
99.21% |
| DGAT-1 inhibitor 2 |
|
|
|
|
|
|
|
95.33% |
| DiaPep277 |
|
|
|
|
|
|
|
99.44% |
| Diptoindonesin G |
|
|
|
|
|
|
|
|
| Displurigen |
|
|
|
|
|
|
|
98.48% |
| DMT003096 |
|
|
|
|
|
|
|
|
| DN401 |
|
|
|
|
|
|
|
98.64% |
| dPDL1-4 |
|
|
|
|
|
|
|
|
| DTHIB |
|
|
|
|
|
|
|
99.82% |
| DTX-P7 |
|
|
|
|
|
|
|
|
| EC144 |
|
|
|
|
|
|
|
98.01% |
| EG36 |
|
|
|
|
|
|
|
|
| EGFR-IN-182 |
|
|
|
|
|
|
|
|
| EV206 |
|
|
|
|
|
|
|
99.62% |
| EZH2/HSP90-IN-29 |
|
|
|
|
|
|
|
|
| Feretoside |
|
|
|
|
|
|
|
98.69% |
| FK 409 |
|
|
|
|
|
|
|
|
| FKBP51-Hsp90-IN-1 |
|
|
|
|
|
|
|
|
| FKBP51-Hsp90-IN-2 |
|
|
|
|
|
|
|
|
| Flavokawain 1i |
|
|
|
|
|
|
|
|
| Gamendazole |
|
|
|
|
|
|
|
99.44% |
| Gamitrinib TPP |
|
|
|
|
|
|
|
|
| Gamitrinib TPP hexafluorophosphate |
|
|
|
|
|
|
|
99.68% |
| Ganetespib |
|
|
|
|
|
|
|
99.94% |
| Gedunin |
|
|
|
|
|
|
|
99.43% |
| Geldanamycin-FITC |
|
|
|
|
|
|
|
92.56% |
| gp96-II |
|
|
|
|
|
|
|
|
| GR-25 |
|
|
|
|
|
|
|
|
| GRP78-IN-1 |
|
|
|
|
|
|
|
|
| GRP78-IN-2 |
|
|
|
|
|
|
|
|
| GRP78-IN-3 |
|
|
|
|
|
|
|
99.88% |
| Grp94 Inhibitor-1 |
|
|
|
|
|
|
|
98.75% |
| Grp94 Inhibitor-2 |
|
|
|
|
|
|
|
|
| Grp94 Inhibitor-3 |
|
|
|
|
|
|
|
|
| Grp94-IN-3 |
|
|
|
|
|
|
|
|
| GUT-70 |
|
|
|
|
|
|
|
|
| H2-Gamendazole |
|
|
|
|
|
|
|
98.20% |
| HA15 |
|
|
|
|
|
|
|
99.98% |
| HA15-Biotin |
|
|
|
|
|
|
|
|
| HDAC/HSP90-IN-1 |
|
|
|
|
|
|
|
|
| HDAC/HSP90-IN-2 |
|
|
|
|
|
|
|
|
| HDAC/HSP90-IN-3 |
|
|
|
|
|
|
|
|
| HDAC/HSP90-IN-4 |
|
|
|
|
|
|
|
|
| HDAC6/HSP90-IN-1 |
|
|
|
|
|
|
|
|
| HDAC6/HSP90-IN-2 |
|
|
|
|
|
|
|
|
| HDAC6/HSP90-IN-3 |
|
|
|
|
|
|
|
|
| HEMTAC WEE1 degrader-1 |
|
|
|
|
|
|
|
99.78% |
| Hexapeptide-11 |
|
|
|
|
|
|
|
99.77% |
| HIF-2α-IN-17 |
|
|
|
|
|
|
|
|
| HM03 |
|
|
|
|
|
|
|
99.51% |
| HM03 trihydrochloride |
|
|
|
|
|
|
|
|
| HS-131 |
|
|
|
|
|
|
|
|
| HS-27 |
|
|
|
|
|
|
|
98.48% |
| HS-72 |
|
|
|
|
|
|
|
|
| HSF1 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Hsf1 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| Hsf1 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| HSF1-IN-1 |
|
|
|
|
|
|
|
|
| HSF1-IN-2 |
|
|
|
|
|
|
|
|
| HSF1-IN-3 |
|
|
|
|
|
|
|
|
| HSF1A |
|
|
|
|
|
|
|
99.94% |
| HSP110-IN-1 |
|
|
|
|
|
|
|
|
| Hsp110-STAT3 PPI-IN-1 |
|
|
|
|
|
|
|
|
| Hsp110-STAT3 PPI-IN-2 |
|
|
|
|
|
|
|
|
| Hsp110/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
| Hsp110/sGC-modulator-1 |
|
|
|
|
|
|
|
99.58% |
| HSP27 inhibitor J2 |
|
|
|
|
|
|
|
99.70% |
| HSP70 ligand 1 |
|
|
|
|
|
|
|
|
| HSP70 ligand 2 |
|
|
|
|
|
|
|
|
| Hsp70-derived octapeptide |
|
|
|
|
|
|
|
98.01% |
| HSP70-IN-1 |
|
|
|
|
|
|
|
98.07% |
| HSP70-IN-3 |
|
|
|
|
|
|
|
|
| HSP70-IN-5 |
|
|
|
|
|
|
|
|
| HSP70-IN-6 |
|
|
|
|
|
|
|
|
| HSP70-IN-7 |
|
|
|
|
|
|
|
|
| HSP70-IN-8 |
|
|
|
|
|
|
|
|
| HSP70-IN-9 |
|
|
|
|
|
|
|
|
| HSP70/DnaK substrate peptide |
|
|
|
|
|
|
|
|
| HSP70/DnaK substrate peptide TFA |
|
|
|
|
|
|
|
98.06% |
| Hsp70/FoxM1-IN-1 |
|
|
|
|
|
|
|
|
| HSP70/SIRT2-IN-1 |
|
|
|
|
|
|
|
|
| HSP70/SIRT2-IN-2 |
|
|
|
|
|
|
|
|
| Hsp70TAC BRD4 Degrader-1 |
|
|
|
|
|
|
|
|
| Hsp70TAC PD-1 Degrader-2 |
|
|
|
|
|
|
|
|
| Hsp90-Cdc37-IN-1 |
|
|
|
|
|
|
|
99.66% |
| Hsp90-Cdc37-IN-2 |
|
|
|
|
|
|
|
|
| Hsp90-Cdc37-IN-3 |
|
|
|
|
|
|
|
98.09% |
| Hsp90-Cdc37-IN-4 |
|
|
|
|
|
|
|
|
| HSP90-IN-10 |
|
|
|
|
|
|
|
|
| HSP90-IN-11 |
|
|
|
|
|
|
|
|
| HSP90-IN-12 |
|
|
|
|
|
|
|
|
| HSP90-IN-13 |
|
|
|
|
|
|
|
|
| HSP90-IN-14 |
|
|
|
|
|
|
|
|
| Hsp90-IN-15 |
|
|
|
|
|
|
|
|
| Hsp90-IN-17 |
|
|
|
|
|
|
|
|
| Hsp90-IN-17 hydrochloride |
|
|
|
|
|
|
|
99.31% |
| HSP90-IN-18 |
|
|
|
|
|
|
|
|
| HSP90-IN-19 |
|
|
|
|
|
|
|
|
| HSP90-IN-20 |
|
|
|
|
|
|
|
|
| HSP90-IN-22 |
|
|
|
|
|
|
|
98.0% |
| HSP90-IN-23 |
|
|
|
|
|
|
|
98.25% |
| HSP90-IN-25 |
|
|
|
|
|
|
|
|
| HSP90-IN-27 |
|
|
|
|
|
|
|
95.0% |
| HSP90-IN-28 |
|
|
|
|
|
|
|
|
| HSP90-IN-29 |
|
|
|
|
|
|
|
|
| HSP90-IN-30 |
|
|
|
|
|
|
|
|
| HSP90-IN-32 |
|
|
|
|
|
|
|
|
| HSP90-IN-33 |
|
|
|
|
|
|
|
|
| Hsp90-IN-34 |
|
|
|
|
|
|
|
|
| HSP90-IN-35 |
|
|
|
|
|
|
|
|
| Hsp90-IN-36 |
|
|
|
|
|
|
|
|
| Hsp90-IN-37 |
|
|
|
|
|
|
|
97.0% |
| Hsp90-IN-38 |
|
|
|
|
|
|
|
|
| Hsp90-IN-39 |
|
|
|
|
|
|
|
|
| Hsp90-IN-40 |
|
|
|
|
|
|
|
|
| Hsp90-IN-41 |
|
|
|
|
|
|
|
|
| Hsp90-IN-42 |
|
|
|
|
|
|
|
|
| Hsp90-IN-43 |
|
|
|
|
|
|
|
|
| Hsp90-IN-44 |
|
|
|
|
|
|
|
|
| Hsp90-IN-45 |
|
|
|
|
|
|
|
|
| Hsp90-IN-46 |
|
|
|
|
|
|
|
|
| Hsp90-IN-47 |
|
|
|
|
|
|
|
|
| Hsp90-IN-48 |
|
|
|
|
|
|
|
|
| HSP90-IN-9 |
|
|
|
|
|
|
|
|
| HSP90/LSD1-IN-1 |
|
|
|
|
|
|
|
|
| HSP90/mTOR-IN-1 |
|
|
|
|
|
|
|
|
| HSP90i |
|
|
|
|
|
|
|
|
| HSP90i-COCH2CH2-PEG4-NHBoc |
|
|
|
|
|
|
|
|
| HSP90α-IN-1 |
|
|
|
|
|
|
|
|
| Hsp90β decapeptide |
|
|
|
|
|
|
|
|
| Hsp90β-IN-1 |
|
|
|
|
|
|
|
|
| Hsp90β-IN-2 |
|
|
|
|
|
|
|
|
| HVH-2930 |
|
|
|
|
|
|
|
96.54% |
| HYOU1-IN-1 |
|
|
|
|
|
|
|
98.32% |
| Icapamespib |
|
|
|
|
|
|
|
99.60% |
| Icapamespib hydrochloride |
|
|
|
|
|
|
|
98.74% |
| iHSP110-33 |
|
|
|
|
|
|
|
99.59% |
| Iroxanadine |
|
|
|
|
|
|
|
|
| Iroxanadine hydrobromide |
|
|
|
|
|
|
|
|
| Iroxanadine hydrochloride |
|
|
|
|
|
|
|
|
| Iroxanadine sulfate |
|
|
|
|
|
|
|
|
| Iso-PU-H54 |
|
|
|
|
|
|
|
|
| Isoxazole |
|
|
|
|
|
|
|
99.98% |
| JD-02 |
|
|
|
|
|
|
|
|
| JG-231 |
|
|
|
|
|
|
|
98.47% |
| JG-258 |
|
|
|
|
|
|
|
|
| JG-48 |
|
|
|
|
|
|
|
|
| JG-98 |
|
|
|
|
|
|
|
99.88% |
| KHS101 |
|
|
|
|
|
|
|
|
| KHS101 hydrochloride |
|
|
|
|
|
|
|
99.65% |
| KNK423 |
|
|
|
|
|
|
|
|
| KNK437 |
|
|
|
|
|
|
|
99.04% |
| Kongensin A |
|
|
|
|
|
|
|
98.0% |
| KRIBB11 |
|
|
|
|
|
|
|
99.69% |
| KU-177 |
|
|
|
|
|
|
|
98.54% |
| KU-32 |
|
|
|
|
|
|
|
|
| KUNB106 |
|
|
|
|
|
|
|
|
| KUNB31 |
|
|
|
|
|
|
|
98.9% |
| KUNG29 |
|
|
|
|
|
|
|
|
| KUNG65 |
|
|
|
|
|
|
|
98.84% |
| KUNG94 |
|
|
|
|
|
|
|
|
| KW-2478 |
|
|
|
|
|
|
|
99.53% |
| KW-2478 hydrochloride |
|
|
|
|
|
|
|
|
| Liriodendrin |
|
|
|
|
|
|
|
99.02% |
| Luminespib |
|
|
|
|
|
|
|
99.40% |
| Lw13 |
|
|
|
|
|
|
|
|
| Ly101-4B |
|
|
|
|
|
|
|
|
| MA191 |
|
|
|
|
|
|
|
|
| MAL3-101 |
|
|
|
|
|
|
|
98.22% |
| Malonganenone A |
|
|
|
|
|
|
|
|
| MAO A/HSP90-IN-1 |
|
|
|
|
|
|
|
|
| MAO A/HSP90-IN-2 |
|
|
|
|
|
|
|
|
| Metalnikowin I |
|
|
|
|
|
|
|
|
| MitoBloCK-10 |
|
|
|
|
|
|
|
98.99% |
| MK2-IN-1 |
|
|
|
|
|
|
|
99.04% |
| MK2-IN-1 hydrochloride |
|
|
|
|
|
|
|
98.24% |
| MK2-IN-5 |
|
|
|
|
|
|
|
|
| MK2-IN-5 acetate |
|
|
|
|
|
|
|
99.64% |
| MKT-077 |
|
|
|
|
|
|
|
98.49% |
| ML189 |
|
|
|
|
|
|
|
|
| ML229 |
|
|
|
|
|
|
|
|
| ML346 |
|
|
|
|
|
|
|
98.25% |
| Monorden diacetate |
|
|
|
|
|
|
|
|
| MPC-3100 |
|
|
|
|
|
|
|
98.4% |
| MPD-1 |
|
|
|
|
|
|
|
|
| MRLB-223 |
|
|
|
|
|
|
|
|
| NBE5 |
|
|
|
|
|
|
|
|
| NCT-58 |
|
|
|
|
|
|
|
99.63% |
| NDNA3 |
|
|
|
|
|
|
|
|
| NDNA4 |
|
|
|
|
|
|
|
|
| Neoantimycin |
|
|
|
|
|
|
|
|
| NMS-E973 |
|
|
|
|
|
|
|
99.61% |
| NN-01-195 |
|
|
|
|
|
|
|
|
| NSC-134754 |
|
|
|
|
|
|
|
|
| NSC145366 monohydrochloride |
|
|
|
|
|
|
|
|
| NVP-HSP990 |
|
|
|
|
|
|
|
99.49% |
| NXP800 |
|
|
|
|
|
|
|
99.86% |
| O-Carboranylphenoxyacetanilide |
|
|
|
|
|
|
|
|
| Onalespib |
|
|
|
|
|
|
|
99.92% |
| Onalespib lactate |
|
|
|
|
|
|
|
|
| p5 Ligand for Dnak and DnaJ |
|
|
|
|
|
|
|
|
| Palmitic acid calcium |
|
|
|
|
|
|
|
|
| Palmitic acid-d4 |
|
|
|
|
|
|
|
99.88% |
| PDK-IN-1 |
|
|
|
|
|
|
|
99.74% |
| PET-16 |
|
|
|
|
|
|
|
98.07% |
| Pifithrin-μ |
|
|
|
|
|
|
|
99.69% |
| Pimitespib |
|
|
|
|
|
|
|
99.87% |
| PKHB1 |
|
|
|
|
|
|
|
99.84% |
| Pochonin D |
|
|
|
|
|
|
|
|
| Poly (I:C):Kanamycin (1:1) |
|
|
|
|
|
|
|
48.60% |
| Polyinosinic-polycytidylic acid |
|
|
|
|
|
|
|
99.40% |
| Polyinosinic-polycytidylic acid (GMP Like) |
|
|
|
|
|
|
|
90.5% |
| PROTAC BRD4 Degrader-21 |
|
|
|
|
|
|
|
|
| PROTAC HSP70 Degrader-1 |
|
|
|
|
|
|
|
|
| PROTAC HSP90 degrader BP3 |
|
|
|
|
|
|
|
99.54% |
| PROTAC Hsp90α degrader 1 |
|
|
|
|
|
|
|
98.30% |
| Psa-AR |
|
|
|
|
|
|
|
|
| PSEC13 |
|
|
|
|
|
|
|
|
| PU-11 |
|
|
|
|
|
|
|
|
| PU-20F |
|
|
|
|
|
|
|
|
| PU-H39 |
|
|
|
|
|
|
|
|
| PU-H54 |
|
|
|
|
|
|
|
99.04% |
| PU-WS13 |
|
|
|
|
|
|
|
99.88% |
| PU24FCl |
|
|
|
|
|
|
|
|
| PU3 |
|
|
|
|
|
|
|
|
| Questiomycin A |
|
|
|
|
|
|
|
98.20% |
| Rosolutamide |
|
|
|
|
|
|
|
≥98.0% |
| S1g-10 |
|
|
|
|
|
|
|
99.08% |
| SEW84 |
|
|
|
|
|
|
|
99.73% |
| SGC8158 |
|
|
|
|
|
|
|
97.6% |
| Shepherdin (79-87) |
|
|
|
|
|
|
|
|
| Shepherdin (79-87) TFA |
|
|
|
|
|
|
|
98.83% |
| SMTIN-P01 |
|
|
|
|
|
|
|
|
| SMTIN-T140 |
|
|
|
|
|
|
|
99.54% |
| Smurf1-IN-A01 |
|
|
|
|
|
|
|
99.81% |
| SNX-0723 |
|
|
|
|
|
|
|
99.12% |
| SNX-2112 |
|
|
|
|
|
|
|
99.49% |
| SNX-5422 |
|
|
|
|
|
|
|
98.72% |
| SNX-5422 mesylate |
|
|
|
|
|
|
|
|
| SNX-7081 |
|
|
|
|
|
|
|
|
| SST0116CL1 |
|
|
|
|
|
|
|
|
| SST0116CL1 free base |
|
|
|
|
|
|
|
|
| STA-1474 |
|
|
|
|
|
|
|
|
| STA-2842 |
|
|
|
|
|
|
|
|
| Sudachitin |
|
|
|
|
|
|
|
|
| SW02 |
|
|
|
|
|
|
|
98.3% |
| Tasiamide B |
|
|
|
|
|
|
|
|
| TBPH |
|
|
|
|
|
|
|
95.0% |
| Teprenone Impurity 5 |
|
|
|
|
|
|
|
|
| TRAP1-IN-1 |
|
|
|
|
|
|
|
96.03% |
| TRAP1-IN-2 |
|
|
|
|
|
|
|
|
| TRC051384 |
|
|
|
|
|
|
|
99.79% |
| TRC051384 hydrochloride |
|
|
|
|
|
|
|
|
| VER-155008 |
|
|
|
|
|
|
|
99.82% |
| VER-49009 |
|
|
|
|
|
|
|
99.45% |
| VER-50589 |
|
|
|
|
|
|
|
99.76% |
| VER-82576 |
|
|
|
|
|
|
|
98.76% |
| Versipelostatin |
|
|
|
|
|
|
|
|
| Vicanicin |
|
|
|
|
|
|
|
|
| VWK147 |
|
|
|
|
|
|
|
|
| Wighteone |
|
|
|
|
|
|
|
98.71% |
| Withanolide D |
|
|
|
|
|
|
|
|
| WK88-1 |
|
|
|
|
|
|
|
|
| XL888 |
|
|
|
|
|
|
|
99.41% |
| XYD049 |
|
|
|
|
|
|
|
99.46% |
| Xylobiose |
|
|
|
|
|
|
|
98.0% |
| YK5 |
|
|
|
|
|
|
|
99.66% |
| YM-08 |
|
|
|
|
|
|
|
|
| YM-1 |
|
|
|
|
|
|
|
98.49% |
| YM-1 tosylate |
|
|
|
|
|
|
|
|
| YUM70 |
|
|
|
|
|
|
|
98.01% |
| YZ129 |
|
|
|
|
|
|
|
99.85% |
| Zelavespib |
|
|
|
|
|
|
|
99.93% |
| Zelavespib formic |
|
|
|
|
|
|
|
97.39% |
| Zelavespib hydrochloride |
|
|
|
|
|
|
|
99.25% |
| Zinc picolinate |
|
|
|
|
|
|
|
|
| Ethoxyquin |
|
|
|
|
|
|
|
98.76% |
| Palladium(Ⅱ) acetylacetonate |
|
|
|
|
|
|
|
98.0% |
| Zinc acetate |
|
|
|
|
|
|
|
99.05% |
| Sodium lactate ringer's solution |
|
|
|
|
|
|
|
|
| Dihydroberberine |
|
|
|
|
|
|
|
99.30% |
| Falcarinol |
|
|
|
|
|
|
|
99.83% |
| Tamoxifen-d5 |
|
|
|
|
|
|
|
99.77% |
| Tamoxifen (Standard) |
|
|
|
|
|
|
|
99.94% |
| Tamoxifen-13C6 |
|
|
|
|
|
|
|
|
| Tamoxifen |
|
|
|
|
|
|
|
99.96% |
| Tamoxifen-d3 hydrochloride |
|
|
|
|
|
|
|
98.99% |
| Tamoxifen-d3 |
|
|
|
|
|
|
|
|
| Palmitic acid sodium |
|
|
|
|
|
|
|
95.0% |
| Palmitic acid-13C8 sodium |
|
|
|
|
|
|
|
|
| Tin(II) palmitate |
|
|
|
|
|
|
|
|
| Flavokawain C |
|
|
|
|
|
|
|
99.53% |
| Azadiradione |
|
|
|
|
|
|
|
|
| Bicyclol |
|
|
|
|
|
|
|
99.91% |
| Tubeimoside I |
|
|
|
|
|
|
|
99.96% |
| Tanespimycin |
|
|
|
|
|
|
|
99.01% |
| Tanespimycin-d5 |
|
|
|
|
|
|
|
|
| Azure C |
|
|
|
|
|
|
|
65.15% |
| 2-O-β-D-Glucopyranosyl-L-ascorbic acid |
|
|
|
|
|
|
|
95.0% |
| Novobiocin |
|
|
|
|
|
|
|
97.88% |
| Novobiocin sodium |
|
|
|
|
|
|
|
99.07% |
| Nonactin |
|
|
|
|
|
|
|
99.0% |
| Teprenone |
|
|
|
|
|
|
|
99.31% |
| Tamoxifen Citrate |
|
|
|
|
|
|
|
99.88% |
| Radicicol |
|
|
|
|
|
|
|
99.72% |
| Geldanamycin |
|
|
|
|
|
|
|
99.58% |
| Palmitic acid |
|
|
|
|
|
|
|
99.86% |
| Palmitic acid-1-13C |
|
|
|
|
|
|
|
98.0% |
| Palmitic acid-13C |
|
|
|
|
|
|
|
98.0% |
| Palmitic acid-13C16 |
|
|
|
|
|
|
|
99.72% |
| Palmitic acid-13C2 |
|
|
|
|
|
|
|
99.54% |
| Palmitic acid-1,2,3,4-13C4 |
|
|
|
|
|
|
|
99.9% |
| Palmitic acid-d2-1 |
|
|
|
|
|
|
|
|
| Palmitic acid-d3 |
|
|
|
|
|
|
|
99.88% |
| Palmitic acid-d31 |
|
|
|
|
|
|
|
99.92% |
| Palmitic acid-13C sodium |
|
|
|
|
|
|
|
98.0% |
| Palmitic acid-13C-1 |
|
|
|
|
|
|
|
|
| Palmitic acid-15,15,16,16,16-d5 |
|
|
|
|
|
|
|
|
| Palmitic acid-9,10-d2 |
|
|
|
|
|
|
|
|
| Palmitic acid-d |
|
|
|
|
|
|
|
99.90% |
| Palmitic acid-d17 |
|
|
|
|
|
|
|
|
| Palmitic acid-d2 |
|
|
|
|
|
|
|
98.0% |
| Palmitic acid-d2-2 |
|
|
|
|
|
|
|
|
| Palmitic acid-d2-3 |
|
|
|
|
|
|
|
|
| Palmitic acid-d2-4 |
|
|
|
|
|
|
|
|
| Palmitic acid-d2-5 |
|
|
|
|
|
|
|
|
| Palmitic acid-d4-2 |
|
|
|
|
|
|
|
|
| Palmitic acid-d4-1 |
|
|
|
|
|
|
|
99.80% |
| Palmitic acid-d5 |
|
|
|
|
|
|
|
|
| Palmitic acid-d9 |
|
|
|
|
|
|
|
|
| Palmitic acid-13C16 sodium |
|
|
|
|
|
|
|
99.1% |
| Rocaglamide |
|
|
|
|
|
|
|
98.76% |
| Bimoclomol |
|
|
|
|
|
|
|
99.29% |
| Ursolic acid acetate |
|
|
|
|
|
|
|
98.0% |
| Regaloside C |
|
|
|
|
|
|
|
99.62% |
| Retaspimycin |
|
|
|
|
|
|
|
|
| Retaspimycin Hydrochloride |
|
|
|
|
|
|
|
95.49% |
| Paeoniflorin |
|
|
|
|
|
|
|
98.94% |
| Benzbromarone |
|
|
|
|
|
|
|
99.91% |
| Solanesol |
|
|
|
|
|
|
|
98.0% |
| Solanesol (Standard) |
|
|
|
|
|
|
|
95% |
| Cucurbitacin D |
|
|
|
|
|
|
|
99.93% |
| Glutamic acid sodium salt |
|
|
|
|
|
|
|
99.92% |
| Hexadecanoate-13C16 potassium |
|
|
|
|
|
|
|
98.40% |
| Eupalinolide A |
|
|
|
|
|
|
|
99.92% |
| Alvespimycin |
|
|
|
|
|
|
|
99.52% |
| Alvespimycin TFA |
|
|
|
|
|
|
|
98.97% |
| Alvespimycin hydrochloride |
|
|
|
|
|
|
|
98.80% |